Clinical case of long-term use of osimertinib in the treatment of EGFR mutation-positive lung adenocarcinoma
This article reviews clinical case of epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer and the usage of osimertinib for its treatment. Targeted drugs, EGFR tyrosine kinase inhibitors were approved for the treatment of non-small cell lung cancer more than 15 years...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | RU |
| Publié: |
IP Habib O.N.
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/35b34aa048204aa58f62d993ec1f67bc |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|